Shandong Hualian Medical Technology

Shandong Hualian Medical Technology is a medical big data research and development provider founded in 2018. The company, led by CEO Zhang Ye, operates as the technology transfer partner for China's National Health and Medical Big Data Research Institute, focusing on commercializing and promoting health data technologies through an industry-academia-research collaborative model.

The firm develops and provides big data and blockchain-based software for the healthcare sector. Its core offering is a "Medical Science Data Collaboration Network," a platform built on causal inference algorithms for medical big data. This network provides services such as data governance, distributed big data collaboration, and a data governance SaaS platform to medical institutions, research facilities, and universities. The business model aims to create a closed-loop system encompassing medical big data, scientific research data, and evidence-based medicine to empower advancements in clinical research, pharmaceuticals, artificial intelligence, and health management.

In March 2023, the company secured tens of millions of RMB in an Angel funding round. The round was led by Shandong Industry Research Venture Capital and Jinan New Kinetic Energy Artificial Intelligence Venture Capital, with participation from industry partner OpenPie.

Keywords: healthcare data, big data, blockchain technology, healthtech, data governance, medical research platform, clinical research, data collaboration, enterprise software, SaaS, data management systems, medical AI, evidence-based medicine, data trading, causal inference algorithms, scientific data network